NewEdge Wealth’s Repligen RGEN Stock Holding History

NewEdge Wealth’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,492	Closed	-$244K	–	1260
2025 Q4	$244K	Buy	1,492 +75	+5%	+$11.7K	﹤0.01%	1096
2025 Q3	$207K	Sell	1,417 -3,670	-72%	-$446K	﹤0.01%	982
2025 Q2	$577K	Buy	+5,087	New	+$647K	0.01%	673

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

NewEdge Wealth's RGEN Position: Q1 2026 in Review

NewEdge Wealth sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,492 shares — an estimated $244K sold.

NewEdge Wealth first reported a position in RGEN in Q2 2025 and held it in 3 quarters. The position peaked at $577K in Q2 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

NewEdge Wealth reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
NewEdge Wealth sold 1,492 Repligen shares in Q1 2026, an estimated $244K.
NewEdge Wealth first reported a position in Repligen in Q2 2025 and held it in 3 quarters.
NewEdge Wealth's Repligen position peaked at $577K in Q2 2025.
444 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.